Trial Profile
Efficacy and Tolerability of Dydrogesterone and Intravaginal Progesterone in the Luteal Phase Support.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Dydrogesterone (Primary) ; Progesterone (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 24 Sep 2011 Planned End Date changed from 1 Oct 2010 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 28 Aug 2010 New trial record